Tech Company Financing Transactions

Ocera Therapeutics Funding Round

Greenspring Global Partners, CDIB Bioscience and Cross Creek Capital invested in a $35.5 million Series C funding round for Ocera Therapeutics. This venture round was announced on 2/20/2008.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
Funds will be used for continuing trials of the company's lead candidates.

Company Information

Company Status
Acquired or Merged
Mailing Address
525 University Avenue 610
Palo Alto, CA 94301
Email Address
Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.
Ocera Therapeutics LinkedIn Company Profile
Social Media
Ocera Therapeutics Company Twitter Account
Company News
Ocera Therapeutics News
Ocera Therapeutics on Facebook
Ocera Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Linda Grais
  Linda Grais LinkedIn Profile  Linda Grais Twitter Account  Linda Grais News  Linda Grais on Facebook
Chief Financial Officer
Michael Byrnes
  Michael Byrnes LinkedIn Profile  Michael Byrnes Twitter Account  Michael Byrnes News  Michael Byrnes on Facebook
VP - Sales
Gaurav Aggarwal
  Gaurav Aggarwal LinkedIn Profile  Gaurav Aggarwal Twitter Account  Gaurav Aggarwal News  Gaurav Aggarwal on Facebook



Browse more venture capital transactions:

Prev: 2/20/2008: Bleacher Report venture capital transaction
Next: 2/20/2008: Incipient venture capital transaction


Share this article


About Our VC Transactions Data

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary